A clinical trial involving using Avita Medical’s (ASX:AVH) ReCell Spray-on Skin to treat skin pigment disorders has hit its 10-patient recruitment goal. [ + ]

Genetic Technologies (ASX:GTG) has arranged for insurance claims for its BREVAGen breast cancer risk test to be adjudicated in-network with an eighth US PPO. [ + ]

A new research Chair at the ANU will be funded by Sirtex Medical. [ + ]

Prima BioMed (ASX:PRR) has received approval to extend its CANVAS cancer vaccine study to South Korea, the first Asian country to be involved in the phase II/III trial. [ + ]

Findings of the 12-year AusDiab follow-up study show that Australians aren’t making the lifestyle changes needed to address obesity, high blood pressure and diabetes. [ + ]

In the US, the Food and Drug Administration has allowed marketing of the bioMérieux VITEK mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans. [ + ]

Research published in the journal PLOS ONE, conducted by Rori Rohlfs and colleagues from the University of California at Berkeley and New York University, indicates that familial search methods may identify distant relatives as being closer to the perpetrator than they actually are. [ + ]

AusBiotech has commended the Labor government’s response to the Strategic Review of Health and Medical Research (The McKeon Review) and its pledge to establish the $250 million Medical Research Innovation Fund (MRIF). [ + ]

Frost & Sullivan has handed iSonea (ASX:ISN) an Innovation Leadership Award for its AsthmaSense cloud mobile health-monitoring technology. [ + ]

The Australian Academy of Science has welcomed the commitments made by the Australian Greens in their science policy, released today. The academy is calling on all parties to articulate a strategic approach to science policy. [ + ]

The Australian Government has committed to growing investment in the health and medical research sector with the Medical Research Innovation Fund. [ + ]

Alchemia (ASX:ACL) said sales of its generic fondaparinux anticoagulant recovered in the June quarter to reach record levels. [ + ]

Janssen and AusBiotech are delighted to announce that the Janssen 2013 Industry Excellence Awards are now open for nominations. The awards, which have three categories, will be announced at AusBiotech 2013 in Brisbane on 30 October. [ + ]

Researchers have found that the SLIRP gene - discovered at the Western Australian Institute for Medical Research (WAIMR) and known to affect hormone action in breast and prostate cancer cells - has an impact on male fertility. [ + ]

WA Premier Colin Barnett has announced a $26m investment in the International Centre for Radio Astronomy Research (ICRAR), based in Perth. The commitment is part of the state’s wider $96m investment in radio astronomy. [ + ]